Cytomegalovirus infection following T-cell depleted allogeneic stem cell transplantation: comparison between two different methods of T-cell depleted

被引:0
|
作者
Chakrabarti, S
Milligan, D
Brown, J
Pamphilon, D
Osman, H
Marks, D
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S92 / S92
页数:1
相关论文
共 50 条
  • [1] A retrospective Dutch study comparing T-cell depleted allogeneic blood stem cell transplantation vs T-cell depleted allogeneic bone marrow transplantation
    Cornelissen, JJ
    Fibbe, WE
    Schattenberg, AVMB
    Petersen, EJ
    Willemze, R
    de Witte, TJM
    Lijwenberg, B
    Verdonck, LF
    Van der Biezen, A
    Brand, R
    TRANSFUSION SCIENCE, 1998, 19 (03): : 196 - 197
  • [2] Allogeneic transplantation of T-cell depleted stem cell grafts followed by T-cell add back.
    Weber-Nordt, RM
    Goldschmidt, H
    Thalheimer, M
    Fruehauf, S
    Goerner, M
    Ho, AD
    BLOOD, 2000, 96 (11) : 399A - 399A
  • [3] Allogeneic T-cell depleted blood stem cell transplantation versus T-cell depleted bone marrow transplantation: a prospective randomized multicenter study
    Cornelissen, J
    Verdonck, L
    Van der Holt, B
    Petersen, E
    Schouten, H
    Russel, L
    Vindelov, L
    Hoglund, M
    Maertens, J
    Maertens, J
    Boogaerts, M
    Lowenberg, B
    BONE MARROW TRANSPLANTATION, 2003, 31 : S40 - S40
  • [4] Comparison of infectious morbidity after allogeneic T-cell depleted peripheral blood progenitor cell transplantation versus T-cell depleted bone marrow transplantation
    Broers, AEC
    van der Holt, B
    Haze, S
    Gratama, JW
    Braakman, E
    Lowenberg, B
    Cornelissen, JJ
    BONE MARROW TRANSPLANTATION, 2004, 33 : S42 - S43
  • [5] Complications after T-CELL depleted allogeneic hematopoietic stem cell transplantation (HSCT).
    Bieri, S
    Roosnek, E
    Helg, C
    Ozsahin, H
    Wacker, P
    Chapuis, B
    Miralbell, R
    Chalandon, Y
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 141 - 141
  • [6] Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant
    Muhsen, Ibrahim N.
    Shaver, Kristen E.
    Wang, Tao
    Wu, Mengfen
    Lulla, Premal
    Ramos, Carlos A.
    Kamble, Rammurti T.
    Heslop, Helen E.
    Carrum, George
    Hill, LaQuisa C.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (12): : 1193e1 - 1193e8
  • [7] Infectious complications following T-cell depleted hematopoietic stem-cell transplantation
    Novitzky, N
    Rouskova, A
    CYTOTHERAPY, 2001, 3 (03) : 165 - 173
  • [8] T-Cell Depleted RIC Allogeneic Stem Cells Transplantation: A Platform for Immunotherapy
    Raymakers, R.
    Levenga, H.
    Schattenberg, T.
    Maas, F.
    Esendam, B.
    Fredrix, H.
    de Witte, T.
    Dolstra, H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S32 - S32
  • [9] Langerhans cell chimerism early after T-cell depleted allogeneic haematopoietic stem cell transplantation
    Schneiker, K.
    Schmitt, T.
    Konur, A.
    Hemmerling, J.
    Bender, K.
    von Stebut, E.
    Hadian, A.
    Kolbe, K.
    Huber, C.
    Herr, W.
    Meyer, R. G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S62 - S62
  • [10] Improved outcome after T-cell depleted allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Simonetta, F.
    Casini, A.
    Wilk, M.
    Ecsedi, M.
    Andres, M.
    Gerull, S.
    Masouridi-Levrat, S.
    Beauverd, Y.
    Mohty, B.
    Bucher, C.
    Stern, M.
    Manz, M.
    Nair, G.
    Schanz, U.
    Passweg, J.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S292 - S292